Health BehaviorNCT06592443
The LvL UP Trial: Assessing the Effectiveness of a mHealth Intervention
A study testing LvL UP, LvL UP + MI and Comparison in people with Health Behavior and Noncommunicable Diseases, run by Singapore ETH Centre at 2 sites in Singapore.
Trial summary
Non-communicable diseases (NCDs), such as cardiovascular disease, diabetes, or cancer, and common mental disorders (CMDs), such as depression or anxiety, represent the primary causes of death and disability worldwide, causing major health and financial burdens. Read more about this study
- Who is it for?
- Ages 21 to 59 yearsHealthy volunteers can take part
- Conditions the study is for
- Health Behavior, Noncommunicable Diseases, Mental Health Issue
- What is being tested?
- LvL UP, LvL UP + MI and Comparison
- Type of treatment
- Injection or infusion, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,061 participants
- Where
- 2 sitesSingapore
- Study dates
- 21 Oct 2024to 26 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 59 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- aged 21 to 59 years,
- Singapore citizens, permanent residents, or foreigners residing in Singapore on long-term passes with at least 1 year of validity remaining,
- planning to reside in Singapore for the duration of the study (eligible participants can undertake sporadic trips overseas, as long as these do not conflict with in-person study visits),
- proficient in English (the LvL UP app is currently only available in English),
- owners of a smartphone (minimum requirements: iOS version 12.4 and Android version 8) with internet access,
- able to provide informed consent, and
- identified as 'at risk' of developing non-communicable diseases and/or common mental disorders.
Who cannot join
- diagnosed with one of the following chronic diseases: heart disease (e.g., heart attack and stroke), cancer, chronic respiratory diseases (e.g., chronic obstructed pulmonary disease and asthma), diabetes (type 1 or type 2), or chronic kidney disease.
- diagnosed with one of the following mental disorders: major depressive disorders (depression), bipolar, eating disorders, post-traumatic stress disorder (PTSD), anxiety disorders, severe personality disorder, substance use disorders, or other mental health conditions diagnosed by a mental health professional.
- pregnant, (iv) currently taking medications prescribed for high blood pressure or high blood glucose.
- past or current LvL UP users, including participants from the LvL UP pilot trial (NCT06360029) or HAPPY trial (Harnessing Human Potential and Improving Health Span in Women and their Children Trial).
- already participating or planning to participate in the LvL UP trial as a 'LvL UP Buddy\'.
- enrolled or planning to enroll in another lifestyle intervention research study before or during the study period.
Trial locations and contacts
2 sites in 1 country.
Singapore2 sites
Saw Swee Hock School of Public Health
Singapore, 117549
Singapore ETH Center
Singapore, 138602
About this study
Official title: The LvL UP Trial: A Sequential, Multiple Assignment, Randomized Controlled 2 Trial to Assess the Effectiveness of a Blended Mobile Lifestyle Intervention
Non-communicable diseases (NCDs), such as cardiovascular disease, diabetes, or cancer, and common mental disorders (CMDs), such as depression or anxiety, represent the primary causes of death and disability worldwide, causing major health and financial burdens. Lifestyle behaviours, including physical activity, diet, stress and emotional regulation, tobacco smoking, alcohol consumption, and sleep are important modifiable risk factors associated with the prevention and management of both NCDs and CMDs.
LvL UP is a mHealth intervention aimed at preventing NCDs and CMDs in adults from multi-ethnic Southeast Asian populations. Building upon leading evidence- and theory-based frameworks in the areas of mental health and behaviour change, a multidisciplinary team of researchers developed LvL UP as a holistic intervention centred around three core pillars: Move More, Eat Well, Stress Less.
This study is aimed at (i) evaluating the effectiveness and cost-effectiveness of LvL UP, an mHealth lifestyle intervention for the prevention of NCDs and CMDs, and (ii) establishing the optimal blended approach in LvL UP that balances effective personalized lifestyle support with scalability.
Read the detailed description
Participants will:
- Visit the study site at baseline and month 6 to complete assessments.
- Complete online assessments at months 1, 3, 9 and 12.
- Be assigned to group 1 (intervention) or group 2 (comparison).
- Participants in group 1 will download the LvL UP App.
- Participants in group 1 categorized as non-responders; at month 1 will start receiving six motivational interviewing coaching sessions in addition to continue using the LvL UP app (LvL UP + MI).
- Participants in group 2 will receive a package with standard lifestyle resources from Singapore Health Promotion Board.
Participants will be randomly allocated to groups 1 or 2 (LvL UP or comparison) following a 2:1 ratio favoring the LvL UP group. At month 1 (decision point), participants from the LvL UP group will be classified as responders or non-responders based on pre-specified criteria. Non-responder participants will be re-randomized with equal probability (1:1) to one of the two second-line conditions: (i) continuing with the initial intervention (LvL UP) or (ii) additional MI support sessions (LvL UP + MI). The LvL UP pilot study results (NCT06360029) will be used to inform the tailoring variable(s) for the trial (i.e., to define response / non-response at month 1). Engagement and app evaluation variables (e.g., number of app components completed over the first 4 weeks, net promoter score), preliminary intervention effects (e.g., initial positive response), or a combination of the two will be used.
Participants will also take part in a process evaluation informed by the UK Medical Research Council guidelines to explore implementation (process, fidelity, dose, adaptations, reach), mechanisms of action (participant experience and response to intervention, mediators, unexpected pathways and consequences), and contextual factors that may affect implementation and intervention outcomes. Methods will entail qualitative and quantitative approaches, including surveys, interviews, web-based and app-based analytic data, and direct observation. In addition, other measures have been added to the research protocol to address the following exploratory aims (all relevant measures are described in the outcomes section):
- To identify the most cost-effective intervention condition from the societal perspective (e.g., self-reported sickness absence).
- To explore time-varying and baseline moderators on intervention outcomes (e.g., sociodemographic variables, personality).
- To investigate behavior maintenance by assessing the intervention outcomes at six months of follow-up (i.e., 12 months after baseline).
- To investigate which smartphone sensor data might be effective in predicting user state of receptivity to LvL UP notifications (receptivity: the likelihood of engaging with a LvL UP notification, operationalized as higher response rate and decreased response time).
- To investigate which signals (e.g., audio signals, usage patterns) are most useful for predicting the presence of subclinical depression, anxiety, stress and/or other mental health conditions.
- To validate a 7-day modified Food Frequency Questionnaire based on My Healthy Plate recommendations by Singapore Health Promotion Board (HPB).
- To develop and evaluate a supervised non-responder / dropout prediction model using retrospective user app engagement data from the trial.
- To explore views on climate and climate change and assess their perceived impact (including impact on health behaviours).
The study was powered to compare the baseline to 6 months change in mental well-being between LvL UP (A+B) and the comparison condition and between LvL UP + adaptive MI (A+C) versus the comparison condition (primary objective). For both comparisons, we assume the effect size (Cohen's d) for well-being to be 0.3 and the responder rate to stage 1 intervention (LvL UP) to be 50%. The effect size was estimated by aggregating data from five meta-analyses on mHealth interventions and their reported impact on participant's mental well-being. To obtain a marginal power of at least 80% with a two-tailed Type I error rate of 5% for each outcome, 458 participants will be required; we further buffer for 73% retention following a recent meta-analysis estimate for digital health interventions lasting more than 8 weeks, rounding the number for a final sample size of 650. Therefore, 217 participants will be randomized to the comparison condition, and 433 participants will be randomized to start with stage 1 intervention (LvL UP), of which we estimate about 217 participants (50% non-responders) will be re-randomized to either continue with LvL UP or receive MI at stage 2 (LvL UP + adaptive MI). Participants randomized to group 1 (LvL UP) are asked to nominate a LvL UP Buddy, which will take part in the process evaluation. The total sample size is thus 1,073 (650 as main participants and 423 as LvL UP Buddies). The above sample size calculations might be refined based on the LvL UP pilot study results.
- Being tested
- LvL UP, LvL UP + MI, Comparison
- Keywords
- Prevention, Healthy lifestyle, Physical activity, Diet, Mental well-being, Digital health interventions, Mobile Health
- Medical subject headings
- Health Behavior, Noncommunicable Diseases, Risk Reduction Behavior, Motor Activity, Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LvL UPBehavioural
The LvL UP app includes four lifestyle intervention components centred around three core pillars, Move More (physical activity), Eat Well (healthy nutrition), and Stress Less (mental well-being), as follows: (i) conversational agent-delivered health literacy coaching sessions, (ii) daily "Life Hacks" (healthy habit suggestions), (iii) therapeutic Tools including step-based activity tracker, food diary, and journal and (iv) gamified slow-paced breathing training (Breeze). These components are delivered using an innovative engagement approach that combines storytelling, MI, feedback on progress, just-in-time adaptive notifications and gamification.
As part of the LvL UP app onboarding, participants are asked to nominate a 'LvL UP Buddy' (e.g., a friend, family member, or spouse) to provide additional support. Buddies are expected to complete different tasks, such as sending messages of encouragement or engaging in intervention-related activities together with the participant.
LvL UP + MIBehavioural
After 4 weeks, participants categorized as non-responders from the LvL UP group will be re-randomized into second-stage conditions: (i) continuing with the initial intervention (LvL UP) or (ii) additional human-delivered motivational interviewing (MI) support sessions (LvL UP + MI). The MI-informed sessions for non-responders will consist of four sessions delivered via WhatsApp, lasting between 30 and 40 minutes. The content of support will include various MI-based strategies such as use of ask-offer-ask framework and strategic use of communication skills (open-ended questions, reflections, affirmations and summaries) as per four MI processes:
- Engaging (foster collaboration and trust the research staff-user relationship)
- Focusing (conversation to focus on lifestyle changes)
- Evoking (elicit and strengthen participants' motivation towards lifestyle changes), and
- Planning (when the participant is ready, commitment to a change plan aimed at adopting a healthy lifestyle).
ComparisonBehavioural
Participants randomised to the comparison condition will receive a study pack including physical activity, diet and mental well-being content extracted from existing Health Promotion Board (HPB) resources. Established in 2001, the HPB (https://hpb.gov.sg/) is a government organisation under the Ministry of Health committed to promoting healthy living in Singapore. HPB's organises health promotion and disease prevention programmes covering various health domains. HPB-developed resources were selected as the comparator because they are the 'go-to', nation-wide health resources in Singapore which cover LvL UP's domains.
| Study group | Role | What they receive |
|---|---|---|
| LvL UP | Experimental | Downloading and using the LvL UP app Receives: Behavioral: LvL UP |
| LvL UP + MI | Experimental | Downloading and using the LvL UP app + taking part in motivational interviewing support sessions Receives: Behavioral: LvL UP + MI |
| Comparison | Active comparator | Receiving healthy lifestyle and mental well-being resources from Singapore's Health Promotion Board Receives: Behavioral: Comparison |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mental well-being (Warwick-Edinburgh Mental Well-being Scale)
Assessed using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS-14). The total score ranges from 14 to 70, with higher values indicating higher mental well-being.
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Secondary outcomes (21)
Subjective well-being (World Health Organization Well-Being Index)
Assessed using the World Health Organization Well-Being Index (WHO-5). The total score ranges from 0 to 25, with higher values indicating higher well-being.
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Mental health (depression - Patient Health Questionnaire-9)
Assessed using the Patient Health Questionnaire-9. The total score ranges from 0 to 27. Scores of 0-4, 5-9, 10-14, 15-19, 20-27 are the ranges for none, mild, moderate, moderately severe and severe depression, respectively.
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Mental health (stress - Kessler Psychological Distress Scale)
Assessed using the Kessler Psychological Distress Scale (K6). The total score ranges from 10 to 50, with higher values indicating higher levels of psychological distress.
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Health-related quality of life (European Quality of Life 5 Dimensions 5 Level Version)
Assessed using the European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L). The EQ-5D-5L descriptive system of 5 health dimensions (Mobility, Self-care, Usual activities, Pain / discomfort, Anxiety / depression) includes 5 response categories of no problem, slight problems, moderate problems, severe problems, and extreme problems. Health states are scored to give the EQ-5D-5L index using a scoring algorithm from a value set derived from valuation tasks undertaken with general population samples.
Measured: Baseline, month 3, month 6, month 9, month 12
Health behaviours (physical activity - International Physical Activity Questionnaire)
Assessed using the International Physical Activity Questionnaire (IPAQ-long). Results can be reported in categories (low activity levels, moderate activity levels or high activity levels) or as a continuous variable (MET minutes a week).
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Health behaviours (steps - smartphone-based)
Smartphone-based steps
Measured: Throughout the study period (i.e., assessed every day during 12 months)
Health behaviours (sleep - Pittsburgh Sleep Quality Index)
Assessed using the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 27, with higher scores indicating more acute sleep disturbances.
Measured: Baseline, month 6, month 12
Health behaviours (smoking and alcohol consumption - ad hoc questionnaire)
Assessed using a short quantity-frequency survey on smoking and alcohol consumption used in previous epidemiological studies
Measured: Baseline, month 6, month 12
Anthropometry (body weight)
During study visits research staff will assess participants' body weight in kilograms. Weight and height will be combined to report Body Mass Index (BMI) in kg/m2.
Measured: Baseline, month 6
Anthropometry (body height)
During study visits research staff will assess participants' body height in meters. Weight and height will be combined to report Body Mass Index (BMI) in kg/m2.
Measured: Baseline, month 6
Anthropometry (waist circumference)
During study visits research staff will assess participants' waist circumference in meters.
Measured: Baseline, month 6
Anthropometry (hip circumference)
During study visits research staff will assess participants' hip circumference in meters.
Measured: Baseline, month 6
Anthropometry (body composition)
To assess body composition we will use a Tanita MC-780 scale using bioelectrical impedance to register resistance, reactance, lean body mass (kg), and the percentage of body fat.
Measured: Baseline, month 6
Anthropometry (self-reported height and weight)
Self-reported height (kilograms) and weight (meters) via online survey. Weight and height will be combined to report Body Mass Index (BMI) in kg/m2.
Measured: month 1, month 3, month 9, month 12
Resting blood pressure
During study visits research staff will assess diastolic and systolic blood pressure using an automated blood pressure monitor (Dinamap - Carescape V100, GE Pacific).
Measured: Baseline, month 6
Health behaviours (diet quality 1 - diet screener)
Assessed using a 37-item diet screener developed and validated in Singapore
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Health behaviours (diet quality 2 - ad hoc Food Frequency Questionnaire)
Modified 7-item Food Frequency Questionnaire (ad hoc) assessing diet quality
Measured: Baseline, month 1, month 3, month 6, month 9, month 12
Blood metabolic profile (concentration of albumin, creatinine, DHEA-S, HbA1c, hsCRP, TC, HDL, TG, LDL-calculated, random glucose, and full blood count)
During study visits research staff will collect a non-fasting venous blood sample to assess the following blood markers: albumin, creatinine, DHEA-S, HbA1c, hsCRP, lipid panel (TC, HDL, TG and LDL-calculated), random glucose, and full blood count.
Measured: Baseline, month 6
Blood metabolic profile (food intake and health status)
Immediately before the blood drawing procedure participants will be asked about their last food intake and whether they are feeling sick (or have been sick in the past few days), as these have an impact in the blood test results.
Measured: Baseline, month 6
Self-reported health status
Assessed using the following item: "Would you say your health in general is..." (Excellent / Very good / Fair / Poor)
Measured: Baseline, month 3, month 6, month 9, month 12
Change in health status
Assessed using the following item: "Compared with 3 months ago, would you say your health is now..." (Better / Worse / About the same)
Measured: Baseline, month 3, month 6, month 9, month 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start21 Oct 2024
- Primary completion26 Jan 2026
- Study completion26 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Health BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 1,061 participants (actual)
Sponsor and investigators
- Lead sponsor
- Singapore ETH Centre
- Sponsor type
- University, hospital or other
- Collaborators
- ETH Zurich, National University of Singapore, Nanyang Technological University
- Responsible party
- Sponsor
- Investigators
- Falk Mueller-Riemenschneider, Professor, Principal investigator, National University of SingaporeTobias Kowatsch, Professor, Principal investigator, ETH ZurichKonstantina Griva, Professor, Principal investigator, Nanyang Technological University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06592443
- Sponsor's protocol ID
- LvL UP Trial
- Status last verified
- Jan 2026
- First submitted
- 9 Sep 2024
- Last updated
- 28 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Castro O, Mair JL, Salamanca-Sanabria A, Alattas A, Keller R, Zheng S, Jabir A, Lin X, Frese BF, Lim CS, Santhanam P, van Dam RM, Car J, Lee J, Tai ES, Fleisch E, von Wangenheim F, Tudor Car L, Muller-Riemenschneider F, Kowatsch T. Development of "LvL UP 1.0": a smartphone-based, conversational agent-delivered holistic lifestyle intervention for the prevention of non-communicable diseases and common mental disorders. Front Digit Health. 2023 May 10;5:1039171. doi: 10.3389/fdgth.2023.1039171. eCollection 2023.
PubMed 37234382Jabir AI, Lin X, Martinengo L, Sharp G, Theng YL, Tudor Car L. Attrition in Conversational Agent-Delivered Mental Health Interventions: Systematic Review and Meta-Analysis. J Med Internet Res. 2024 Feb 27;26:e48168. doi: 10.2196/48168.
PubMed 38412023Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350:h1258. doi: 10.1136/bmj.h1258.
PubMed 25791983Yan X, Ghosh P, Chakraborty B. Sample size calculation based on precision for pilot sequential multiple assignment randomized trial (SMART). Biom J. 2021 Feb;63(2):247-271. doi: 10.1002/bimj.201900364. Epub 2020 Jun 11.
PubMed 32529788
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The LvL UP Trial: A Sequential, Multiple Assignment, Randomized Controlled 2 Trial to Assess the Effectiveness of a Blended Mobile Lifestyle Intervention
- ClinicalTrials.gov ID
- NCT06592443
- Acronym / sponsor ID
- LvL UP Trial
- Keywords
- Prevention, Healthy lifestyle, Physical activity, Diet, Mental well-being, Digital health interventions, Mobile Health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,061 participants (actual)
- Lead sponsor
- Singapore ETH CentreUniversity, hospital or other
- Collaborators
- ETH Zurich, National University of Singapore, Nanyang Technological University
- Study start
- 21 Oct 2024 (actual)
- Primary completion
- 26 Jan 2026 (actual)
- Study completion
- 26 Jan 2026 (actual)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Non-communicable diseases (NCDs), such as cardiovascular disease, diabetes, or cancer, and common mental disorders (CMDs), such as depression or anxiety, represent the primary causes of death and disability worldwide, causing major health and financial burdens. Lifestyle behaviours, including physical activity, diet, stress and emotional regulation, tobacco smoking, alcohol consumption, and sleep are important modifiable risk factors associated with the prevention and management of both NCDs and CMDs.
LvL UP is a mHealth intervention aimed at preventing NCDs and CMDs in adults from multi-ethnic Southeast Asian populations. Building upon leading evidence- and theory-based frameworks in the areas of mental health and behaviour change, a multidisciplinary team of researchers developed LvL UP as a holistic intervention centred around three core pillars: Move More, Eat Well, Stress Less.
This study is aimed at (i) evaluating the effectiveness and cost-effectiveness of LvL UP, an mHealth lifestyle intervention for the prevention of NCDs and CMDs, and (ii) establishing the optimal blended approach in LvL UP that balances effective personalized lifestyle support with scalability.
Detailed description
Participants will:
- Visit the study site at baseline and month 6 to complete assessments.
- Complete online assessments at months 1, 3, 9 and 12.
- Be assigned to group 1 (intervention) or group 2 (comparison).
- Participants in group 1 will download the LvL UP App.
- Participants in group 1 categorized as non-responders; at month 1 will start receiving six motivational interviewing coaching sessions in addition to continue using the LvL UP app (LvL UP + MI).
- Participants in group 2 will receive a package with standard lifestyle resources from Singapore Health Promotion Board.
Participants will be randomly allocated to groups 1 or 2 (LvL UP or comparison) following a 2:1 ratio favoring the LvL UP group. At month 1 (decision point), participants from the LvL UP group will be classified as responders or non-responders based on pre-specified criteria. Non-responder participants will be re-randomized with equal probability (1:1) to one of the two second-line conditions: (i) continuing with the initial intervention (LvL UP) or (ii) additional MI support sessions (LvL UP + MI). The LvL UP pilot study results (NCT06360029) will be used to inform the tailoring variable(s) for the trial (i.e., to define response / non-response at month 1). Engagement and app evaluation variables (e.g., number of app components completed over the first 4 weeks, net promoter score), preliminary intervention effects (e.g., initial positive response), or a combination of the two will be used.
Participants will also take part in a process evaluation informed by the UK Medical Research Council guidelines to explore implementation (process, fidelity, dose, adaptations, reach), mechanisms of action (participant experience and response to intervention, mediators, unexpected pathways and consequences), and contextual factors that may affect implementation and intervention outcomes. Methods will entail qualitative and quantitative approaches, including surveys, interviews, web-based and app-based analytic data, and direct observation. In addition, other measures have been added to the research protocol to address the following exploratory aims (all relevant measures are described in the outcomes section):
- To identify the most cost-effective intervention condition from the societal perspective (e.g., self-reported sickness absence).
- To explore time-varying and baseline moderators on intervention outcomes (e.g., sociodemographic variables, personality).
- To investigate behavior maintenance by assessing the intervention outcomes at six months of follow-up (i.e., 12 months after baseline).
- To investigate which smartphone sensor data might be effective in predicting user state of receptivity to LvL UP notifications (receptivity: the likelihood of engaging with a LvL UP notification, operationalized as higher response rate and decreased response time).
- To investigate which signals (e.g., audio signals, usage patterns) are most useful for predicting the presence of subclinical depression, anxiety, stress and/or other mental health conditions.
- To validate a 7-day modified Food Frequency Questionnaire based on My Healthy Plate recommendations by Singapore Health Promotion Board (HPB).
- To develop and evaluate a supervised non-responder / dropout prediction model using retrospective user app engagement data from the trial.
- To explore views on climate and climate change and assess their perceived impact (including impact on health behaviours).
The study was powered to compare the baseline to 6 months change in mental well-being between LvL UP (A+B) and the comparison condition and between LvL UP + adaptive MI (A+C) versus the comparison condition (primary objective). For both comparisons, we assume the effect size (Cohen's d) for well-being to be 0.3 and the responder rate to stage 1 intervention (LvL UP) to be 50%. The effect size was estimated by aggregating data from five meta-analyses on mHealth interventions and their reported impact on participant's mental well-being. To obtain a marginal power of at least 80% with a two-tailed Type I error rate of 5% for each outcome, 458 participants will be required; we further buffer for 73% retention following a recent meta-analysis estimate for digital health interventions lasting more than 8 weeks, rounding the number for a final sample size of 650. Therefore, 217 participants will be randomized to the comparison condition, and 433 participants will be randomized to start with stage 1 intervention (LvL UP), of which we estimate about 217 participants (50% non-responders) will be re-randomized to either continue with LvL UP or receive MI at stage 2 (LvL UP + adaptive MI). Participants randomized to group 1 (LvL UP) are asked to nominate a LvL UP Buddy, which will take part in the process evaluation. The total sample size is thus 1,073 (650 as main participants and 423 as LvL UP Buddies). The above sample size calculations might be refined based on the LvL UP pilot study results.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| LvL UP | Experimental | Behavioral: LvL UPDownloading and using the LvL UP app |
| LvL UP + MI | Experimental | Behavioral: LvL UP + MIDownloading and using the LvL UP app + taking part in motivational interviewing support sessions |
| Comparison | Active comparator | Behavioral: ComparisonReceiving healthy lifestyle and mental well-being resources from Singapore's Health Promotion Board |
Who may qualify
- Ages
- 21 to 59 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- aged 21 to 59 years,
- Singapore citizens, permanent residents, or foreigners residing in Singapore on long-term passes with at least 1 year of validity remaining,
- planning to reside in Singapore for the duration of the study (eligible participants can undertake sporadic trips overseas, as long as these do not conflict with in-person study visits),
- proficient in English (the LvL UP app is currently only available in English),
- owners of a smartphone (minimum requirements: iOS version 12.4 and Android version 8) with internet access,
Key exclusion criteria (6 listed)
- diagnosed with one of the following chronic diseases: heart disease (e.g., heart attack and stroke), cancer, chronic respiratory diseases (e.g., chronic obstructed pulmonary disease and asthma), diabetes (type 1 or type 2), or chronic kidney disease.
- diagnosed with one of the following mental disorders: major depressive disorders (depression), bipolar, eating disorders, post-traumatic stress disorder (PTSD), anxiety disorders, severe personality disorder, substance use disorders, or other mental health conditions diagnosed by a mental health professional.
- pregnant, (iv) currently taking medications prescribed for high blood pressure or high blood glucose.
- past or current LvL UP users, including participants from the LvL UP pilot trial (NCT06360029) or HAPPY trial (Harnessing Human Potential and Improving Health Span in Women and their Children Trial).
- already participating or planning to participate in the LvL UP trial as a 'LvL UP Buddy\'.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LvL UPThe LvL UP app includes four lifestyle intervention components centred around three core pillars, Move More (physical activity), Eat Well (healthy nutrition), and Stress Less (mental well-being), as follows: (i) conversational agent-delivered health literacy coaching sessions, (ii) daily "Life Hacks" (healthy habit suggestions), (iii) therapeutic Tools including step-based activity tracker, food diary, and journal and (iv) gamified slow-paced breathing training (Breeze). These components are delivered using an innovative engagement approach that combines storytelling, MI, feedback on progress, just-in-time adaptive notifications and gamification. As part of the LvL UP app onboarding, participants are asked to nominate a 'LvL UP Buddy' (e.g., a friend, family member, or spouse) to provide additional support. Buddies are expected to complete different tasks, such as sending messages of encouragement or engaging in intervention-related activities together with the participant. | Behavioural | LvL UP |
| LvL UP + MIAfter 4 weeks, participants categorized as non-responders from the LvL UP group will be re-randomized into second-stage conditions: (i) continuing with the initial intervention (LvL UP) or (ii) additional human-delivered motivational interviewing (MI) support sessions (LvL UP + MI). The MI-informed sessions for non-responders will consist of four sessions delivered via WhatsApp, lasting between 30 and 40 minutes. The content of support will include various MI-based strategies such as use of ask-offer-ask framework and strategic use of communication skills (open-ended questions, reflections, affirmations and summaries) as per four MI processes: * Engaging (foster collaboration and trust the research staff-user relationship) * Focusing (conversation to focus on lifestyle changes) * Evoking (elicit and strengthen participants' motivation towards lifestyle changes), and * Planning (when the participant is ready, commitment to a change plan aimed at adopting a healthy lifestyle). | Behavioural | LvL UP + MI |
| ComparisonParticipants randomised to the comparison condition will receive a study pack including physical activity, diet and mental well-being content extracted from existing Health Promotion Board (HPB) resources. Established in 2001, the HPB (https://hpb.gov.sg/) is a government organisation under the Ministry of Health committed to promoting healthy living in Singapore. HPB's organises health promotion and disease prevention programmes covering various health domains. HPB-developed resources were selected as the comparator because they are the 'go-to', nation-wide health resources in Singapore which cover LvL UP's domains. | Behavioural | Comparison |
Primary outcome
Mental well-being (Warwick-Edinburgh Mental Well-being Scale)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Assessed using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS-14). The total score ranges from 14 to 70, with higher values indicating higher mental well-being.
21 secondary outcomes
Subjective well-being (World Health Organization Well-Being Index)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Mental health (depression - Patient Health Questionnaire-9)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Mental health (stress - Kessler Psychological Distress Scale)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Health-related quality of life (European Quality of Life 5 Dimensions 5 Level Version)
Time frame: Baseline, month 3, month 6, month 9, month 12
Health behaviours (physical activity - International Physical Activity Questionnaire)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Health behaviours (steps - smartphone-based)
Time frame: Throughout the study period (i.e., assessed every day during 12 months)
Health behaviours (sleep - Pittsburgh Sleep Quality Index)
Time frame: Baseline, month 6, month 12
Health behaviours (smoking and alcohol consumption - ad hoc questionnaire)
Time frame: Baseline, month 6, month 12
Anthropometry (body weight)
Time frame: Baseline, month 6
Anthropometry (body height)
Time frame: Baseline, month 6
Anthropometry (waist circumference)
Time frame: Baseline, month 6
Anthropometry (hip circumference)
Time frame: Baseline, month 6
Anthropometry (body composition)
Time frame: Baseline, month 6
Anthropometry (self-reported height and weight)
Time frame: month 1, month 3, month 9, month 12
Resting blood pressure
Time frame: Baseline, month 6
Health behaviours (diet quality 1 - diet screener)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Health behaviours (diet quality 2 - ad hoc Food Frequency Questionnaire)
Time frame: Baseline, month 1, month 3, month 6, month 9, month 12
Blood metabolic profile (concentration of albumin, creatinine, DHEA-S, HbA1c, hsCRP, TC, HDL, TG, LDL-calculated, random glucose, and full blood count)
Time frame: Baseline, month 6
Blood metabolic profile (food intake and health status)
Time frame: Baseline, month 6
Self-reported health status
Time frame: Baseline, month 3, month 6, month 9, month 12
Change in health status
Time frame: Baseline, month 3, month 6, month 9, month 12
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2026.
- Background: PubMed 37234382Castro O, Mair JL, Salamanca-Sanabria A, Alattas A, Keller R, Zheng S, Jabir A, Lin X, Frese BF, Lim CS, Santhanam P, van Dam RM, Car J, Lee J, Tai ES, Fleisch E, von Wangenheim F, Tudor Car L, Muller-Riemenschneider F, Kowatsch T. Development of "LvL UP 1.0": a smartphone-based, conversational agent-delivered holistic lifestyle intervention for the prevention of non-communicable diseases and common mental disorders. Front Digit Health. 2023 May 10;5:1039171. doi: 10.3389/fdgth.2023.1039171. eCollection 2023.
- Background: PubMed 38412023Jabir AI, Lin X, Martinengo L, Sharp G, Theng YL, Tudor Car L. Attrition in Conversational Agent-Delivered Mental Health Interventions: Systematic Review and Meta-Analysis. J Med Internet Res. 2024 Feb 27;26:e48168. doi: 10.2196/48168.
- Background: PubMed 25791983Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350:h1258. doi: 10.1136/bmj.h1258.
- Background: PubMed 32529788Yan X, Ghosh P, Chakraborty B. Sample size calculation based on precision for pilot sequential multiple assignment randomized trial (SMART). Biom J. 2021 Feb;63(2):247-271. doi: 10.1002/bimj.201900364. Epub 2020 Jun 11.
- Individual participant dataSharing planned: No
Related trials for Health Behavior
Not yet recruitingObservational study
Validation of the Healthcare Relationship Assessment Scale (ERA) in Health Sciences Students.
Health Adult Subjects, Communication
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Falk Mueller-Riemenschneider, Professor principal investigator
National University of Singapore
Tobias Kowatsch, Professor principal investigator
ETH Zurich
Konstantina Griva, Professor principal investigator
Nanyang Technological University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing LvL UP, LvL UP + MI and Comparison in people with Health Behavior and Noncommunicable Diseases, run by Singapore ETH Centre at 2 sites in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mental well-being (Warwick-Edinburgh Mental Well-being Scale) (time frame: Baseline, month 1, month 3, month 6, month 9, month 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06592443, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.